Cleveland, Ohio 44124


Purpose:

Hypothesis: Women who use Actonel (risedronate) for osteopenia will show beneficial periodontal effects.


Study summary:

Women who use Actonel for osteopenia will show beneficial attachment loss, alveolar bone height and morphology as compared to those who do not when oral hygiene is corrected for.


Criteria:

Inclusion Criteria: - Osteopenia - Postmenopausal Exclusion Criteria: - Male - Diabetes


NCT ID:

NCT00594334


Primary Contact:

Principal Investigator
james liu, md
UHCMC

leena palomo, dds msd
Phone: 2163686300
Email: leena.palomo@case.edu


Backup Contact:

Email: james.liu@uhhospitals.org
james liu, md
Phone: 2168443888


Location Contact:

Cleveland, Ohio 44124
United States



There is no listed contact information for this specific location.

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.